---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-023045"
form_type: "8-K"
ticker: "SNDX"
cik: "0001395937"
company_name: "Syndax Pharmaceuticals Inc"
filed_at: "2022-06-13T23:59:59+00:00"
generated_at: "2026-06-25T02:17:30.207762+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Syndax appoints Keith A. Goldan as CFO; base salary $450k, option for 230k shares

## Summary
- Keith Goldan appointed CFO effective June 13, 2022; previously CFO at OptiNose.
- Employment terms: $450k base salary, 40% target bonus, option for 230k shares (4-yr vest), $50k RSU sign-on.
- Sharon Klahre named VP, Investor Relations and Communications, reporting to Goldan.
- Goldan brings ~30 years biopharma CFO experience; co. expects multiple pivotal readouts in 2023.

## SEC filing metadata
- accession: 0001564590-22-023045
- form_type: 8-K
- ticker: SNDX
- cik: 0001395937
- company_name: Syndax Pharmaceuticals Inc
- filed_at: 2022-06-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1395937/000156459022023045/0001564590-22-023045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1395937/000156459022023045/sndx-8k_20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-023045
- JSON: https://secwatch.observer/filing/0001564590-22-023045.json
- Plain text: https://secwatch.observer/filing/0001564590-22-023045.txt

## Key facts
- Executive change
  Keith A. Goldan was appointed as Chief Financial Officer at Syndax Pharmaceuticals Inc.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On June 13, 2022, Syndax Pharmaceuticals, Inc. (the “ Company ”) issued a press release announcing that Keith A. Goldan will join the Company as Chief Financial Officer, effective June 13, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1395937/000156459022023045/0001564590-22-023045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.